US 10550192
Antigen-binding proteins that antagonize leptin receptor
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 10550192 (Antigen-binding proteins that antagonize leptin receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P